- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2019 · career development · Young Investigator Award
Dissecting the Oncogenic Function of YAP1 in Colorectal Cancer.
David Mayhew · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2019 · career development · Career Development Award
Circulating human papillomavirus (HPV) cell-free (cf)DNA in head and neck cancer
Glenn Hanna · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award
Targeting The Transcriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
Isaac Klein · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2019 · fellowship · AACR-Amgen Fellowships in Clinical/Translational Cancer Research
Defining the differentiation states of myeloma at single cell resolution
Julia Frede · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2019 · career development · Young Investigator Award
Mobile Health intervention to reduce treatment care-continuum delays among breast cancer patients in Rwanda.
Temidayo Fadelu · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award
Small Molecule-induced KRAS Degradation for the Treatment of KRAS-mutant Cancer
Alexander Parent · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2019 · fellowship · AACR-AstraZeneca START Grants
The role of the DNA damage response in prostate cancer EZH2 sensitivity
Neel Shah · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2019 · career development · Young Investigator Award
Experiences with Home Symptom Management Among Parents of Children with Cancer
Maya Ilowite · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2019–2026 · cooperative agreement · UG1
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
Harold John Burstein · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2028 · research · R01
Development and vascularity of intestinal mesenchyme
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · research · R35
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2030 · research · R01
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2027 · research · R01
PGC1alpha Pathway: Novel Intracellular and Extracellular Mediators
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2030 · research · R35
Data Analysis Tools for Emerging High-throughput Technologies
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
Thomas M Roberts · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2027 · research · R01
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
Nabihah Tayob · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · career development · K00
Effects of Extracellular Mechanics on Mechanosensory and Central Neuron Function
Joy Ann Franco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2028 · research · R01
Defining mechanisms of extracellular succinate regulation over metabolic tissue function
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Sample Processing and Immune Assessment
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Targeting histone methylation in PTCL
Sandeep Dave · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Synergistic combinations that target apoptosis induction in PTCL
Birgit Knoechel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Targeting oncogenic TCR signaling in PTCL
Markus Müschen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Administrative Support
Robert Jon Soiffer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Administrative Core
Markus Müschen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · program · P01
Biostatistics and Data Management
Haesook T Kim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · program · P01
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT
Robert Jon Soiffer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Biostatistics and Data Management
Haesook T Kim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Samples and Models Core
Steven Horwitz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Antigenic basis of immune responses after immune modulatory therapies post-HCT
Catherine Ju-Ying Wu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · program · P01
Administrative Support
Robert Jon Soiffer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Administrative Core
Markus Müschen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Defining the scope and clinical impact of donor CHIP after allogeneic HCT
Robert Coleman Lindsley · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · program · P01
Sample Processing and Immune Assessment
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · program · P01
Defining the scope and clinical impact of donor CHIP after allogeneic HCT
Robert Coleman Lindsley · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Synergistic combinations that target apoptosis induction in PTCL
Birgit Knoechel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Targeting oncogenic TCR signaling in PTCL
Markus Müschen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Single Cell and Immunogenomics
Kenneth James Livak · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Targeting histone methylation in PTCL
Sandeep Dave · Dana-Farber Cancer Institute · funded by National Institutes of Health
